Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the 13C-Urea Breath Test in Helicobacter pylori-Positive Patients.

Background and Aim: Vonoprazan (VPZ) is a new oral potassium-competitive acid blocker that has recently become available. The aim of this study was to investigate the effects of VPZ on the urease activity of H. pylori as measured by the 13C-urea breath test (13C-UBT).Patients and Methods: A total of...

Descripción completa

Detalles Bibliográficos

Publicado en:	Digestive Diseases & Sciences Vol. 62; no. 3; pp. 739 - 746
Autores principales:	Takimoto, Mayu, Tomita, Toshihiko, Yamasaki, Takahisa, Fukui, Shota, Taki, Masato, Okugawa, Takuya, Kondo, Takashi, Kono, Tomoaki, Tozawa, Katsuyuki, Arai, Eitatsu, Ohda, Yoshio, Oshima, Tadayuki, Fukui, Hirokazu, Watari, Jiro, Miwa, Hiroto
Formato:	research randomized controlled trial Journal Article
Publicado:	Springer Nature Mar2017
Acceso en línea:	Ver este registro en EBSCOhost